FCBT
CLSD

First Citizens Bank & Trust’s Clearside Biomedical CLSD Stock Holding History

First Citizens Bank & Trust’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$28K – 388
2020
Q2 		$28K Buy
+1,000
New +$29.4K ﹤0.01% 391

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

First Citizens Bank & Trust's CLSD Position: Q3 2020 in Review

First Citizens Bank & Trust sold out of Clearside Biomedical (CLSD) in Q3 2020, closing a stake of 1,000 shares — an estimated $28K sold.

First Citizens Bank & Trust first reported a position in CLSD in Q2 2020 and held it in 1 quarter. The position peaked at $28K in Q2 2020. 41 funds tracked by Wall St. Rank hold CLSD as of Q3 2020.

  • First Citizens Bank & Trust reported no remaining Clearside Biomedical position as of Q3 2020 after selling out during the quarter.
  • First Citizens Bank & Trust sold 1,000 Clearside Biomedical shares in Q3 2020, an estimated $28K.
  • First Citizens Bank & Trust first reported a position in Clearside Biomedical in Q2 2020 and held it in 1 quarter.
  • First Citizens Bank & Trust's Clearside Biomedical position peaked at $28K in Q2 2020.
  • 41 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2020.

Based on First Citizens Bank & Trust's 13F filing for Q3 2020, filed 15 Oct 2020.